Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,82 USD | +0,71% |
|
-1,40% | -51,38% |
Attività
Numero di dipendenti: 46
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Compounds
100,0
%
| 41 | 100,0 % | 49 | 100,0 % | +19,95% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 41 | 100,0 % | 49 | 100,0 % | +19,95% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 07/03/14 |
Justin File
DFI | Director of Finance/CFO | 53 | 12/06/23 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Eric Deng
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/21 |
Jason Sausser
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Richard Ghalie
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/03/16 |
David Walsey
IRC | Investor Relations Contact | - | 01/02/18 |
Eugene Park
SAM | Sales & Marketing | - | 01/07/21 |
Anne Frese
HRO | Human Resources Officer | - | 22/06/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 26/02/18 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 11/02/13 |
Charles Baltic
CHM | Chairman | 63 | 20/10/11 |
Nick Glover
BRD | Director/Board Member | 55 | 11/06/13 |
David Urso
CEO | Chief Executive Officer | 60 | 07/03/14 |
Steven Wood
BRD | Director/Board Member | 41 | 31/10/23 |
Director/Board Member | 33 | 31/10/23 | |
James Flynn
BRD | Director/Board Member | 43 | 31/10/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 6 662 857 | 6 636 883 ( 99,61 %) | 0 | 99,61 % |
Coordinate società
![Indirizzo MEI Pharma, Inc.(MEIP)](https://cdn.zonebourse.com/static/address/12212540.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-51,38% | 18,79 Mln | |
+16,59% | 44,44 Mrd | |
-10,62% | 37,68 Mrd | |
+41,93% | 39,84 Mrd | |
+29,92% | 31,46 Mrd | |
-9,78% | 27,02 Mrd | |
+12,34% | 26,29 Mrd | |
+41,53% | 13,8 Mrd | |
+31,49% | 12,46 Mrd | |
-7,40% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione MEIP
- Società MEI Pharma, Inc.